|RFx ID :||24644645|
|Tender Name :||Future Procurement Opportunity (FPO) - Supply of Trastuzumab|
|Reference # :||A1436422|
|Open Date :||Q3 2021|
|Indicative RFx Release Date :||Q3 2022 [?]|
|Tender Type :||Future Procurement Opportunity (FPO)|
|Project Status :||Initial development [?]|
|Indicative Total Value :||$100M + [?]|
|Expected number of contracts offered :||1|
|Tender Coverage :||Sole Agency [?]|
|Required Pre-qualifications :||None|
Pharmac Procurement Team
Pharmac is planning on issuing a competitive process for supply of trastuzumab.
The approximate gross annual expenditure of trastuzumab in the 2020 FYR was $35,000,000. Information related to the listing of trastuzumab on the Pharmaceutical Schedule, including current funding restrictions is available on the PHARMAC website.